MedPath

Electromagnetic fields for drug-resistant cystitis

Not Applicable
Recruiting
Conditions
Chronic drug-resistant E. Coli cystitis.
Interstitial cystitis (chronic)
N30.1
Registration Number
IRCT20211022052833N3
Lead Sponsor
CRESO S.r.l.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
148
Inclusion Criteria

Women, age 18 to 80 years,
Women suffering from chronic E-coli indued drug-resistant cystitis. Chronic cystitis will be defined as at least 3 episodes of cystitis per year. The women with chronic cystitis will be labelled as drug-resistant if they have previously used six types of antibiotics (trimethoprim, nitrofurantoin, fluoroquinolones, sulfonamides, amoxicillin, and ampicillin) for at least 2 months without satisfactory clinical response.

Exclusion Criteria

History of myocardial infarction
Stroke
Uncontrolled diabetes
Cancer
Allergic skin reactions
Any other condition that can affect participation in the trial

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Detecting E. coli levels greater than 100,000 CFU/ml. Timepoint: Pre and post-treatment (1 month). Method of measurement: Urine analysis and Urine culture: Urine analysis will be conducted using refractometric and cytofluorimetric methods following SIBioC guidelines, and urine culture will be performed using a conventional method according to AMCLI and EUCAST guidelines.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath